Actively Recruiting
IOP Reduction in Pigmentary Glaucoma Using DSLT
Led by Mann Eye Institute · Updated on 2026-04-09
45
Participants Needed
1
Research Sites
54 weeks
Total Duration
On this page
Sponsors
M
Mann Eye Institute
Lead Sponsor
S
Sengi
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
CONDITIONS
Official Title
IOP Reduction in Pigmentary Glaucoma Using DSLT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with pigmentary dispersion syndrome with elevated IOP or mild to moderate pigmentary glaucoma with glaucomatous optic neuropathy and corresponding visual field or RNFL loss
- Treatment naive or washed out IOP ranging from 6518-34 mmHg
- Central corneal thickness (CCT) 480-600 bcm
- Able to complete medication washout and follow-up
You will not qualify if you...
- Prior incisional glaucoma surgery or glaucoma-related procedures in the study eye
- Prior laser trabeculoplasty less than 3 years ago
- Prior intraocular surgery and refractive surgery, except for cataract surgery unless greater than 2 years ago
- Patients anticipating cataract surgery within the follow-up period
- History of ocular inflammation and infection
- All other secondary glaucoma including exfoliative
- Patients unable to have DSLT treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mann Eye Institute
Houston, Texas, United States, 76134-2099
Actively Recruiting
Research Team
M
Melissa Wright
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here